Davis's Drug Guide
clesrovimab
General
Pronunciation:
kles-roe-vye-mab
Trade Name(s)
- Enflonsia
Ther. Class.
Pharm. Class.
monoclonal antibodies
fusion inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Clesrovimab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580167/all/clesrovimab.
Vallerand AHA, Sanoski CAC. Clesrovimab. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580167/all/clesrovimab. Accessed August 12, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Clesrovimab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580167/all/clesrovimab
Vallerand AHA, Sanoski CAC. Clesrovimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 12]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580167/all/clesrovimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - clesrovimab
ID - 3580167
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580167/all/clesrovimab
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
